Category:
Chiral Intermediates
CAS NO:
960404-48-2
Standard:
USP,In-house Standards,
A hydrate that consists of dapagliflozin compounded with (S)-propylene glycol and hydrate in a (1:1:1) ratio. Used to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Dapagliflozin ((2S)-1,2-propanediol, hydrate) is a stable diastereomeric salt form of the SGLT2 inhibitor. Molecular Formula: C16H25NO7·C3H8O2·nH2O; CAS No: 1049383-47-2. Synthesized via glycosylation and coupling reactions under strict anhydrous conditions.
Store below -20°C in desiccated environment to prevent hydrolysis. Avoid direct contact with skin and eyes; use appropriate PPE during handling. Contraindicated in severe renal impairment patients.